Chat with us
Research Assistance
Online
  • Please enter your first name.

Spain Aesthetic Injectable Market, 2026-2033

The aesthetic injectable market in Spain is expected to reach a projected revenue of US$ 444.4 million by 2033. A compound annual growth rate of 9% is expected of Spain aesthetic injectable market from 2026 to 2033.
Revenue, 2025 (US$M)
$220.7
Estimate, 2026 (US$M)
$242.3
Forecast, 2033 (US$M)
$444.4
CAGR, 2026 - 2033
9.0%
Spain Aesthetic Injectable Market, 2021-2033 (US$M)

This page contains premium content. Request sample data or start your free trial to explore Horizon.

  • ✔ Access to global market statistics
  • ✔ Access to company profiles
  • ✔ Free use-cases & research insights

No credit card required*

Global Market

Related Markets

Spain aesthetic injectable market highlights

  • The Spain aesthetic injectable market generated a revenue of USD 220.7 million in 2025 and is expected to reach USD 444.4 million by 2033.
  • The Spain market is expected to grow at a CAGR of 9% from 2026 to 2033.
  • In terms of segment, botulinum toxin (botox) was the largest revenue generating product in 2025.
  • PLLA is the most lucrative product segment registering the fastest growth during the forecast period.


Aesthetic injectable market data book summary

Market revenue in 2025USD 220.7 million
Market revenue in 2033USD 444.4 million
Growth rate9% (CAGR from 2026 to 2033)
Largest segmentBotulinum toxin (botox)
Fastest growing segmentPLLA
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationCollagen and PMMA Microspheres, Hyaluronic Acid, Calcium Hydroxylapatite (CaHA), PLLA, PCL, PN/PDRN, Botulinum Toxin (Botox)
Key market players worldwideIpsen SA, AbbVie Inc, Merz Pharma, Galderma Group AG Registered Shares, Prollenium Medical Technologies, Suneva Medical, Sinclair Pharma plc, Medytox, Revance Therapeutics Inc


Other key industry trends

  • In terms of revenue, Spain accounted for 2.0% of the global aesthetic injectable market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Europe, UK aesthetic injectable market is projected to lead the regional market in terms of revenue in 2033.
  • UK is the fastest growing regional market in Europe and is projected to reach USD 1,037.3 million by 2033.

In Spain, aesthetics is a flourishing industry. The country ranks fifth in Europe in terms of cosmetics and perfume consumption, which can be attributed to increasing aesthetic consciousness.

Moreover, the growing urban population, rising number of novel approved products, easy availability of affordable treatments, rapid advancements in noninvasive procedures, and increasing number of cosmetic professionals are among the factors contributing to the market growth in Spain.

However, the growing number of shipments of unregulated products from Spain is expected to impede international confidence in aesthetic injectables. For instance, in May 2023, more than 70 shipments of unregulated Botox and Juvederm were identified on the U.S. coast, and the products originated from four primary locations: Spain, Bulgaria, China, & South Korea.

No credit card required*

Publish Date: Apr 28, 2026

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Three ways to get this data

Subscribe to the databook, customize it, or ask a question.

Horizon Databook

Unlock every chart on this page and get dashboard access

  • Statistics1.2M+ across all markets
  • Databooks30K+ global, 120K+ country
  • Companies200K+ profiles
  • ExportPDF, Dashboard, XLS & PNG, licensed to cite

Ask Prism AI

A cited answer in seconds

  • Corpus30,000 studies, 1.2M points
  • ScopeAll markets, not just this
  • CitationTraced to report & table
  • HonestySays "not covered" if so
  • SpeedSeconds, not days
ISO 9001 & 27001 certifiedESOMAR memberNot sure which fits? Call +1-415-854-0727

Aesthetic Injectable Market Companies

NameProfile# EmployeesHQWebsite
AbbVie IncView profile 50,0001 North Waukegan Road, North Chicago, IL, United States, 60064-6400www.abbvieinvestor.com
Galderma Group AG Registered SharesView profile -Zählerweg 10, Zug, Switzerland, 6300www.galderma.com
Revance Therapeutics IncView profile 5971222 Demonbreun Street, Suite 2000, Nashville, TN, United States, 37203www.revance.com
Merz PharmaView profile 5001-10000Deutsch, Sachsen, Germany, Europewww.merz.com
Suneva MedicalView profile 101-250San Diego, California, United States, North Americasunevamedical.com
Prollenium Medical TechnologiesView profile 101-250Richmond Hill, Ontario, Canada, North Americaprollenium.com
Sinclair Pharma plcView profile 501-1000London, England, United Kingdom, Europewww.sinclairpharma.com/
MedytoxView profile 501-1000Seoul, Seoul-t'ukpyolsi, South Korea, Asiawww.medytox.com/page/company_en?site_id=en
Ipsen SAView profile 5,32565 Quai Georges Gorse, Billancourt Cedex, Boulogne, France, 92100www.ipsen.com

Spain Aesthetic Injectable Market

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Aesthetic Injectable Market will help companies and investors design strategic landscapes.


Botulinum Toxin (Botox) was the largest segment with a revenue share of 52.51% in 2025.

Horizon Databook has segmented the Spain aesthetic injectable market based on collagen and pmma microspheres, hyaluronic acid, calcium hydroxylapatite (caha), plla, pcl, pn/pdrn, botulinum toxin (botox) covering the revenue growth of each sub-segment from 2021 to 2033.




In Spain, aesthetics is a flourishing industry. The country ranks fifth in Europe in terms of cosmetics and perfume consumption, which can be attributed to increasing aesthetic consciousness.

Moreover, the growing urban population, rising number of novel approved products, easy availability of affordable treatments, rapid advancements in noninvasive procedures, and increasing number of cosmetic professionals are among the factors contributing to the market growth in Spain.

However, the growing number of shipments of unregulated products from Spain is expected to impede international confidence in aesthetic injectables. For instance, in May 2023, more than 70 shipments of unregulated Botox and Juvederm were identified on the U.S. coast, and the products originated from four primary locations: Spain, Bulgaria, China, & South Korea.

  • Spain Aesthetic Injectable Market Product Outlook (Revenue, USD Million , 2021-2033)
    • Collagen and PMMA Microspheres
    • Hyaluronic Acid
    • Calcium Hydroxylapatite (CaHA)
    • PLLA
    • PCL
    • PN/PDRN
    • Botulinum Toxin (Botox)
  • Spain Aesthetic Injectable Market Application Outlook (Revenue, USD Million , 2021-2033)
    • Wrinkle Correction
    • Lip Augmentation
    • Facial Contouring
    • Scar Treatment
    • Volume Loss Restoration
    • Others
  • Spain Aesthetic Injectable Market End Use Outlook (Revenue, USD Million , 2021-2033)
    • MedSpas
    • Aesthetic Surgery Centers
    • Hospitals
    • Others

Reasons to subscribe to Aesthetic Injectable Market databook

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Aesthetic Injectable Market databook

  • Our clientele includes a mix of Aesthetic Injectable Market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Spain Aesthetic Injectable Market, including forecasts for subscribers. This country databook contains high-level insights into Spain Aesthetic Injectable Market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Spain Aesthetic Injectable Market, 2021-2033 (US$M)

No Access Stack Chart

Spain Product - Aesthetic Injectable Market, 2025 - 2033 (US$M)

No Access Pie Chart

Spain Product - Aesthetic Injectable Market, 2025 - 2033 (USD Million)

No Access

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more